Take-home naloxone (THN) economic evaluation

Summary of the evidence

  • Beneficial

Community distribution of naloxone was the focus of a systematic reviews of economic evaluations (Cherrier et al., 2022, 10 studies, one cost-effectiveness analysis, eight cost-utility analyses, and one cost-benefit analysis) and results showed that:

  • all studies concluded that community distribution of naloxone was cost effective, with an incremental cost-utility ratio range of $US111-58,738 (year 2020 values) per quality-adjusted life-year gained.